Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Vita Life Sciences Limited ( (AU:VLS) ) is now available.
Vita Life Sciences Ltd has reported a change in the shareholdings of director Henry George Townsing, reflecting an adjustment in his indirect interests across several related entities and investment vehicles. The filing outlines his direct and indirect holdings in ordinary shares before and after the transactions, providing updated transparency on his total beneficial stake in the company.
Townsing disposed of 40,753 ordinary shares via market trades over 5–7 May 2026, for consideration of approximately $101,983, reducing his combined direct and indirect holdings from 640,014 to 599,261 shares. The notice details the specific entities through which these shares are held, ensuring regulatory compliance and giving shareholders clearer visibility into board-level ownership changes and potential governance implications.
More about Vita Life Sciences Limited
Vita Life Sciences Ltd is a health and wellness company listed on the ASX, focused on developing, manufacturing and marketing nutritional, pharmaceutical and related healthcare products. The company targets consumers seeking preventative health solutions and operates through various entities and investment structures associated with its directors and related parties.
Average Trading Volume: 21,000
Technical Sentiment Signal: Buy
Current Market Cap: A$131.1M
For an in-depth examination of VLS stock, go to TipRanks’ Overview page.